LABSAT
LIVE

Serial Number

79261179

Owner

Lunaphore Technologies SA

Attorney

Courtney Thompson

Filing Date

Feb 20, 2019

Add to watchlist:

No watchlists yet
View on USPTO

LABSAT Trademark

Serial Number: 79261179 • Registration: 5893952

LABSAT is a trademark filed by Lunaphore Technologies SA on February 20, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Lunaphore Technologies SA (7 trademarks)

Route de Lully 5C

Entity Type: 33

Trademark Details

Filing Date

February 20, 2019

Registration Date

October 29, 2019

Published for Opposition

August 13, 2019

Goods & Services

[ Diagnostic substances, preparations and agents for medical use; diagnostic reagents and contrast media for medical use; contrast media for use with medical equipment; diagnostic biomarker reagents for medical purposes; biological and chemical reagents for medical use; diagnostic test reagents for medical use; medical diagnostic reagents and assays for testing of body fluids; biotechnological preparations for medical use for the treatment of cancer and metabolic diseases ]

[ Medical apparatus and instruments for use in immunohistochemistry, in-situ hybridization, immunofluorescence, immunocytochemistry, immunocytofluorescence, and in-situ sequencing; medical apparatus and instruments for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing using fluid technology; diagnostic apparatus for medical use; microfluidic testing apparatus for medical use for testing biomarker expression levels in cell and tissue samples ]

Scientific apparatus and instruments, namely, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of malignant cells or tumors in humans, animals, plants, or microorganisms; optical apparatus and instruments, namely, microscopes, optical profilers, optical filters, optical glasses, optical lens sights, optical scanners, optical readers, optical reflectors; weighing apparatus and instruments, namely, scales and balances; measuring apparatus and instruments, namely, instruments for measuring the quantity of contaminants, pollutants, or malignant cells in animal, plant, or microorganism cells and tissues; signaling apparatus and instruments, namely, signal processors, and signal splitters for electronic apparatus; measuring and testing machines and instruments, namely, digitizers; laboratory apparatus and instruments for use in immunohistochemistry, in-situ hybridization, immunofluorescence, immunocytochemistry, immunocytofluorescence, and in-situ sequencing; microfluidic testing apparatus not for medical use in the form of assay chips, biological assay chips, and sample processing chips; microfluidic systems, namely, sample processing and reagent distribution devices in the nature of rigid plates made of glass and silicon and flexible and stretchable plates made of polymer that include a set of miniaturized fluidic channels and tubes, reservoirs, pumps and microsensors for the study and analysis of chemical and biological samples; apparatus for diagnosis by microfluidics, not for medical use used to diagnose cancer; chips, namely, integrated circuits; microfluidic chips in the nature of integrated circuits; DNA chips; biochips for research or scientific purposes; microchips; microfluidic microchips; micro lab-on-chips, namely, microchips; microprocessors; microfluidic microprocessors; measurement sensors other than for medical use used to measure biomarker expression levels in samples; apparatus, instruments and devices, namely, calculating machines, central processing units and computers for the input, output, transmission, storage, and processing of data, in particular scientific and medical data relating to the presence, absence, or quantity of malignant cells or tumors in humans, animals, plants, or microorganisms collected via immunohistochemistry, in-situ hybridization, immunofluorescence, immunocytochemistry, immunocytofluorescence, and in-situ sequencing; software for use by geneticists and specialists in the bio-medical field featuring scientific and medical data recordings relating to the presence, absence, or quantity of malignant cells or tumors in humans, animals, plants, or microorganisms collected via immunohistochemistry, in-situ hybridization, immunofluorescence, immunocytochemistry, immunocytofluorescence, and in-situ sequencing; bioinformatics software; software for diagnosis and analysis by microfluidics and by immunohistochemistry, in-situ hybridization, immunofluorescence, immunocytochemistry, immunocytofluorescence, and in-situ sequencing

Filing History

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Feb 26, 2026 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
Feb 26, 2026 71.P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 23, 2026 APRE
TEAS SECTION 71 RECEIVED
Oct 29, 2025 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 29, 2024 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Nov 10, 2023 NREP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 6, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Oct 6, 2023 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 6, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 6, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 6, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 6, 2023 COAR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Nov 27, 2020 ADCH
NOTIFICATION PROCESSED BY IB
Jan 16, 2020 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Dec 29, 2019 FICS
FINAL DISPOSITION PROCESSED
Dec 29, 2019 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Nov 28, 2019 GPAR
REGISTERED-PRINCIPAL REGISTER
Oct 29, 2019 R.PR
PUBLISHED FOR OPPOSITION
Aug 13, 2019 PUBO
NOTICE OF PUBLICATION
Jul 24, 2019 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 10, 2019 CNSA
APPLICATION FILING RECEIPT MAILED
Jul 6, 2019 MAFR
ASSIGNED TO EXAMINER
Jul 2, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 2, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 29, 2019 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 20, 2019 REPR